Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Glixis Therapeutics LLC
Profile last edited on: 7/16/2015      CAGE: 5ACM4      UEI: P9J5GS54HL25

Business Identifier: Novel therapies for autoimmune diseases
Year Founded
2012
First Award
2014
Latest Award
2014
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

122 Calistoga Road 346
Santa Rosa, CA 95409
   (818) 633-1244
   N/A
   www.glixis.com/
Location: Single
Congr. District: 05
County: Sonoma

Public Profile

Glixis Therapeutics is focused on glyco-engineering novel therapies for autoimmune disease.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$300,000
Phase II Dollars
$0
Total Awarded
$300,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2014 1 NIH $300,000
Project Title: N-Acetylglucosamine Analogs for the Treatment of Multiple Sclerosis.

Key People / Management

  Ani Oganesyan

Company News

There are no news available.